Camurus AB (publ) (CAMX.ST)
SEK 587.0
(-0.17%)
SEK 587.0
(-0.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 100.95 Million SEK | -6.03% |
| 2022 | 107.43 Million SEK | 0.21% |
| 2021 | 107.2 Million SEK | -3.72% |
| 2020 | 111.34 Million SEK | 236.48% |
| 2019 | 33.09 Million SEK | 236.64% |
| 2018 | 9.83 Million SEK | 176.67% |
| 2017 | 3.55 Million SEK | -71.3% |
| 2016 | 12.38 Million SEK | 281.98% |
| 2015 | 3.24 Million SEK | 361.68% |
| 2014 | 702 Thousand SEK | -80.97% |
| 2013 | 3.68 Million SEK | 62.47% |
| 2012 | 2.27 Million SEK | 164.57% |
| 2011 | 858 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 118.73 Million SEK | 17.61% |
| 2024 Q2 | 127.81 Million SEK | 7.64% |
| 2023 Q3 | 104.09 Million SEK | -2.39% |
| 2023 FY | 100.95 Million SEK | -6.03% |
| 2023 Q1 | 99.44 Million SEK | -7.43% |
| 2023 Q4 | 100.95 Million SEK | -3.02% |
| 2023 Q2 | 106.64 Million SEK | 7.23% |
| 2022 Q1 | 113.68 Million SEK | 6.04% |
| 2022 FY | 107.43 Million SEK | 0.21% |
| 2022 Q4 | 107.43 Million SEK | -8.49% |
| 2022 Q3 | 117.39 Million SEK | -0.02% |
| 2022 Q2 | 117.42 Million SEK | 3.29% |
| 2021 Q4 | 107.2 Million SEK | 2.49% |
| 2021 Q1 | 109.23 Million SEK | -1.9% |
| 2021 Q2 | 105.88 Million SEK | -3.07% |
| 2021 Q3 | 104.59 Million SEK | -1.22% |
| 2021 FY | 107.2 Million SEK | -3.72% |
| 2020 FY | 111.34 Million SEK | 236.48% |
| 2020 Q2 | 82.25 Million SEK | 121.99% |
| 2020 Q3 | 94.54 Million SEK | 14.94% |
| 2020 Q4 | 111.34 Million SEK | 17.78% |
| 2020 Q1 | 37.05 Million SEK | 11.97% |
| 2019 FY | 33.09 Million SEK | 236.64% |
| 2019 Q4 | 33.09 Million SEK | -6.23% |
| 2019 Q3 | 35.29 Million SEK | 44.72% |
| 2019 Q2 | 24.38 Million SEK | 50.65% |
| 2019 Q1 | 16.18 Million SEK | 64.67% |
| 2018 Q3 | 7.22 Million SEK | 14.25% |
| 2018 Q2 | 6.32 Million SEK | 167.39% |
| 2018 Q1 | 2.36 Million SEK | -33.46% |
| 2018 FY | 9.83 Million SEK | 176.67% |
| 2018 Q4 | 9.83 Million SEK | 36.11% |
| 2017 Q3 | 3.11 Million SEK | -77.83% |
| 2017 FY | 3.55 Million SEK | -71.3% |
| 2017 Q1 | 8.25 Million SEK | -33.35% |
| 2017 Q4 | 3.55 Million SEK | 14.1% |
| 2017 Q2 | 14.04 Million SEK | 70.26% |
| 2016 FY | 12.38 Million SEK | 281.98% |
| 2016 Q4 | 12.38 Million SEK | 212.86% |
| 2016 Q3 | 3.95 Million SEK | 25.66% |
| 2016 Q2 | 3.14 Million SEK | -0.25% |
| 2016 Q1 | 3.15 Million SEK | -2.59% |
| 2015 Q1 | - SEK | -100.0% |
| 2015 Q4 | 3.24 Million SEK | 26.11% |
| 2015 FY | 3.24 Million SEK | 361.68% |
| 2015 Q3 | 2.57 Million SEK | 0.0% |
| 2014 Q4 | 702 Thousand SEK | 0.0% |
| 2014 FY | 702 Thousand SEK | -80.97% |
| 2013 FY | 3.68 Million SEK | 62.47% |
| 2012 FY | 2.27 Million SEK | 164.57% |
| 2011 FY | 858 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | - SEK | -Infinity% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| CombiGene AB (publ) | -1.79 Million SEK | 5711.729% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | -319.771% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | 22685.719% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | 11798.16% |
| Alligator Bioscience AB (publ) | 2.00 SEK | -5047749900.0% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | -394.199% |
| Mendus AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Lipum AB (publ) | - SEK | -Infinity% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | -186.568% |
| Simris Alg AB (publ) | 1.09 Million SEK | -9153.437% |
| Spago Nanomedical AB (publ) | 1.00 SEK | -10095499900.0% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | 31535.956% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 5.522% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | -130.591% |
| Ziccum AB (publ) | -4.18 Million SEK | 2510.002% |
| AcouSort AB (publ) | 2.08 Million SEK | -4753.606% |
| Active Biotech AB (publ) | -2500.00 SEK | 4038300.0% |
| Alzinova AB (publ) | -3.27 Million SEK | 3179.775% |
| Amniotics AB (publ) | 534 Thousand SEK | -18805.431% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | -2402.603% |
| Genovis AB (publ.) | 14.9 Million SEK | -577.323% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | 6793841.588% |
| Isofol Medical AB (publ) | - SEK | -Infinity% |
| Intervacc AB (publ) | 10.48 Million SEK | -863.035% |
| Kancera AB (publ) | -1950.00 SEK | 5177279.487% |
| Karolinska Development AB (publ) | - SEK | -Infinity% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 6308.795% |
| NextCell Pharma AB | 545.23 Thousand SEK | -18415.801% |
| Saniona AB (publ) | 1.00 SEK | -10095499900.0% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Xintela AB (publ) | 398 Thousand SEK | -25265.578% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 1514.728% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | -Infinity% |
| Corline Biomedical AB | -3.85 Million SEK | 2717.449% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | -10095400.0% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | -1013.311% |
| Aptahem AB (publ) | - SEK | -Infinity% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | -Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | -3104.921% |
| Biovica International AB (publ) | 2.19 Million SEK | -4490.95% |
| Abliva AB (publ) | - SEK | -Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | -14322.143% |
| 2cureX AB (publ) | -1000.00 SEK | 10095600.0% |
| I-Tech AB | 4.28 Million SEK | -2258.762% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | -930.995% |
| Cyxone AB (publ) | - SEK | -Infinity% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | -Infinity% |
| Biosergen AB | -4.92 Million SEK | 2148.184% |
| Nanologica AB (publ) | 2.97 Million SEK | -3295.728% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| BioInvent International AB (publ) | 11.84 Million SEK | -752.373% |
| Oncopeptides AB (publ) | 2.42 Million SEK | -4063.093% |
| Pila Pharma AB (publ) | 1.00 SEK | -10095499900.0% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | -9720.525% |